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Abstract
Background: Ginseng (Panax ginseng C.A. Meyer) has been used as a traditional herb in the treatment of many
medical disorders. Ginsenosides, which are triterpene derivatives that contain sugar moieties, are the main
pharmacological ingredients in ginseng. This study was designed to investigate the effect of ginsenoside Rg3-
enriched ginseng extract (Rg3GE) on scopolamine-induced memory impairment in mice.
Methods: Rg3GE (50 and 100 mg/kg) were administered to C57BL/6 mice by oral gavage for 14 days (days 1–14).
Memory impairment was induced by scopolamine (1 mg/kg, intraperitoneal injection) for 6 days (days 914). The
Morris water maze test was used to assess hippocampus-dependent spatial memory. The effects of scopolamine
with or without Rg3GE on acetylcholinesterase and nuclear factor-κB (NF-κB) in the hippocampus were also
examined.
Results: Mice with scopolamine treatment alone showed impairments in the acquisition and retention of spatial
memory. Mice that received Rg3GE and scopolamine showed no scopolamine-induced impairment in the
acquisition of spatial memory. Oral administration of Rg3GE suppressed the scopolamine-mediated increase in
acetylcholinesterase activity and stimulation of the NF-κB pathway (i.e., phosphorylation of p65) in the
hippocampus.
Conclusion: These findings suggest that Rg3GE may stabilize scopolamine-induced memory deficits through the
inhibition of acetylcholinesterase activity and NF-κB signaling in the hippocampus.
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Background
Ginseng, the dried root of Panax ginseng C. A. Meyer, has
long been used as a traditional medicine in Asian countries
[1]. It is commonly used for enhancing body strength,
recovering physical balance, and stimulating metabolic
function [1]. Many active ingredients of Panax ginseng,
including ginsenosides, ginseng peptides, and ginseng poly-
saccharides, have been studied extensively for their medi-
cinal properties [2, 3]. Among them, 20(S)-ginsenoside Rg3,
which consists of three parts: a steroid-like backbone
structure, a carbohydrate portion, and an aliphatic side
chain (−CH2CH2CH=C(CH3)2) coupled to carbon-20 of
the backbone structure (Fig. 1a), exhibits neuroprotective
effects in cultured cells and experimental animals [4–6].
The central cholinergic system plays an important role
in regulating memory function. The neurotransmitter
acetylcholine controls numerous cognitive processes [7].
Scopolamine is a nonselective muscarinic acetylcholine
receptor antagonist that interferes with the processes of
learning acquisition and short-term memory in animals
and humans [8, 9]. The hippocampus is particularly vul-
nerable to scopolamine-induced neuronal injury [10].
Scopolamine increases acetylcholinesterase activity in
the hippocampus [11]. The scopolamine-induced mem-
ory impairment model is non-degenerative and shows
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cholinergic dysregulation for which no other relevant
models exist. Thus, scopolamine has been used to gener-
ate experimental animal models for the screening of
anti-amnesic drugs [12].
Ginsenoside Rg3 is not naturally present in Panax gin-
seng [13] and is generated by the loss of the glucose group
linked with the C-20 of ginsenoside Rc, Rd, Rb1, or Rb2
when ginseng roots are heated to a high temperature [14].
It has been reported that red ginseng, which is prepared
by steaming ginseng root at 98–100 °C, only contains
ginsenoside Rg3 [15]. Since ginsenoside Rg3 does not nat-
urally occur in Panax ginseng [13], we prepared ginseng
extract (GE), which is enriched in Rg3 (14.34 ± 0.28 mg/g
of Rg3s and Rg3r (Rg3[s + r])) to investigate whether
Rg3GE has an ameliorating effect on learning and mem-
ory impairment. The Morris water maze test was used to
assess its effect on the scopolamine-induced impairment
of hippocampus-dependent spatial memory. We also ex-
amined the effects of Rg3GE on scopolamine-induced
acetylcholinesterase activity and nuclear factor (NF)-κB
signaling in the hippocampus.
Methods
Materials
Red ginseng extract (RGE), which contains 2.63 ±
0.02 mg/g of Rg3 (s + r), was purchased from KT&G
(Daejeon, South Korea) and used as a positive control.
Scopolamine hydrochloride was purchased from
Sigma-Aldrich (St. Louis, MO, USA). The Amplex Red
Acetylcholine/Acetylcholinesterase assay kit was pur-
chased from Invitrogen (Grand Island, NY, USA).
Antibodies against phosphorylated p65 (p-p65) and β-
actin were purchased from Cell Signaling Technology
(Danvers, MA, USA) and Sigma-Aldrich, respectively.
Preparation of Rg3GE
Rg3-enriched ginseng extract (Rg3GE) was prepared from
the roots of 4-year-old dried Korean ginseng (Panax
Fig. 1 Chemical structure of Rg3 and study design. a Structure of Rg3. b After a 5-day adaption period, the mice were given Rg3GE (50 or
100 mg/kg, p.o.) or RGE (100 mg/kg, p.o.) for a total of 14 days. Beginning on day 9, scopolamine (1 mg/kg, i.p.) was also administered for 6 days,
and the Morris water maze test was used to assess behavior during this period (days 9–14). On day 14, each mouse was sacrificed, and the hippocampus
was removed for the analysis of acetylcholinesterase activity and NF-κB activation. c Groups and treatment
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ginseng C.A. Meyer) from Ginseng Nonghyup (Punggi,
Korea). The ginseng root was extracted three times with
10 volumes of 70 % fermentation ethanol by heat-reflux
extraction at 70 °C for 4 h, and then concentrated twice
under vacuum at 60 °C and 600–700 mmHg. After
extracting in 10 volumes of distilled water at 100 °C for
3 h, the extract was filtered and evaporated. Finally, the
extract solution was lyophilized to obtain powdered gin-
seng extract rich in ginsenoside Rg3 (Rg3GE).
Ginsenoside levels were quantitatively determined using
a high-performance liquid chromatography (HPLC)
system (Agilent, Palo Alto, CA, USA), consisting of an
Agilent 1260 Infinity Quaternary Pump (G1311B), stand-
ard auto-sampler (G1329B), and thermostat column com-
partment (G1316B) equipped with a Peltier cooling and
heating apparatus. Chromatographic separation of major
ginsenosides was performed on a C18-bonded reversed-
phase silica column (Venusil XBP C18, 250 × 4.6 mm, i.d.
5 μm, Bonna-Agela Technology, Newark, DE, USA) at
30 °C. All samples were filtered with a 0.45-μm membrane
before being placed into chromatographic vials (Agilent),
and then placed on the auto-sampler tray. The HPLC
conditions were as follows: solvent A, water; solvent B,
acetonitrile; gradient, 0–20 min (20–24 % B), 20–23 min
(24–27 % B), 23–45 min (27–40 % B), 45–65 min (40–
70 % B), 65–80 min (70–100 % B), 80–90 min (100–20 %
B) with a flow rate of 1.0 ml/min and an injection volume
of 20 μl. The detection was carried out at 203 nm and the
total run time was 90 min. Each standard ginsenoside was
injected for the HPLC analysis, and peaks were assigned
by comparing the retention time (RT) of each peak with
that of each reference compound. The standard ginseno-
sides Rg1, Rb1, Rc, and Rd were obtained from Wako
Pure Chemical Industries, Ltd (Osaka, Japan). Ginsenoside
Rg3(s) and Rg3(r) were from BTGin (Daejeon, Korea).
HPLC analysis of Rg3GE showed that Rg3GE contains
ginsenoside Rg1 (A; 16.61 ± 1.12 mg/g; RT, 14.3 min), Rb1
(B; 47.97 ± 0.59 mg/g; RT, 21.4 min), Rc (C; 39.56 ±
1.67 mg/g; RT, 22.3 min), Rd (D; 17.13 ± 0.65 mg/g; RT,
26.13 min) and Rg3(s + r) (E and F; 14.34 ± 0.28 mg/g; RT,
40.8 min and 41.3 min) (Fig. 2).
Animals
Male C57BL/6 mice (10 weeks, 25–27 g) were purchased
from NARA biotech (Seoul, South Korea) and housed in
a regulated environment (temperature, 21 ± 2 °C; 12-h
light/dark cycle; light period starting at 8 AM) with free
access to food and water. All experimental studies were
submitted to and approved by Konkuk University’s
Council Directive for the Care and Use of Laboratory
Animals (KU11025). To test the effect of Rg3GE on cog-
nitive function, the mice were randomly assigned to five
treatment groups (n = 10 per group, Fig. 1c): 1) non-
induction + vehicle (deionized water), 2) vehicle + sco-
polamine (1 mg/kg/day, 100 μl/day), 3) Rg3GE (50 mg/
kg/day, 150 μl/day) + scopolamine (1 mg/kg/day, 100 μl/
day), 4) Rg3GE (100 mg/kg/day, 150 μl/day) + scopolam-
ine (1 mg/kg/day, 100 μl/day), and 5) RGE (100 mg/kg/
day, 150 μl/day) + scopolamine (1 mg/kg/day, 100 μl/
day). Group 5 was the positive control. Rg3GE and RGE
were suspended in deionized water and administered by
oral gavage (p.o.) on days 1–8, prior to training for the
Morris water maze test, and continued on days 9–14,
during which the mice underwent the Morris water
maze test. Scopolamine was dissolved in deionized water
and administered by intraperitoneal (i.p.) injection on
days 9–14. On days 9–14, Rg3GE and RGE were admin-
istered 60 min before the trial, and scopolamine was
injected 30 min before the trial. Since scopolamine
causes temporary cognitive deficit [16, 17], animal
models for amnesia using scopolamine have been devel-
oped by injecting scopolamine 30 to 60 min before
measuring memory deficit. To investigate the anti-
amnesic activity of drugs, the protocol which applies test
drugs before the scopolamine injection is being used [11,
18–26]. Mouse weights were measured during the treat-
ments with Rg3GE, RGE, and scopolamine on days 1–
14. On day 14, the mice were decapitated immediately
following the Morris water maze test. The hippocampus
was removed, dissected on ice, and frozen at −80 °C
until analysis. Four or three mice hippocampi were ran-
domly selected for acetylcholinesterase activity or west-
ern blot analysis, respectively. They were homogenized
Fig. 2 High-performance liquid chromatography pattern of Rg3GE used in this study. Rg3(s + r) (14.34 ± 0.28 mg/g) was found in Rg3GE. Peaks:
(A) Rg1, (B) Rb1, (C) Rc, (D) Rd, (E) Rg3(s), (F) Rg3(r)
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using Bullet Blender (Next Advance, Averill Park, NY,
USA) in ice-cold Tissue Protein Extraction Reagent
(Thermo Fisher Scientific, Rockford, IL, USA) contain-
ing Phosphatase Inhibitor Cocktail (Sigma-Aldrich),
0.1 mM phenylmethanesulfonylfluoride, and 10 μg/ml
leupetin. Lysates were centrifuged at 19,000 × g for
15 min, and the protein concentrations of the superna-
tants were determined using the Protein Assay Reagent
(Bio-Rad, Hercules, CA, USA). The experimental design
is summarized in Fig. 1b.
Morris water maze test
The water maze test was conducted in a circular tank
(diameter 183 cm, height 58 cm) filled with water main-
tained at 25 ± 2 °C. The tank was divided into four quad-
rants, with a hidden escape platform (diameter, 20 cm;
height, 48 cm) submerged 1.5 cm below the water sur-
face in the center of one quadrant. The mice were
trained to find the hidden platform by learning and
memorizing several visual cues placed outside the maze.
The position of the cues remained unchanged through-
out the experiments. Four trials were conducted on each
day of the training period (days 9–14). Each mouse was
given 60 s to find the hidden platform and allowed to re-
main on it for another 30 s. The swimming speed of
each mouse was measured for days 9–14 during the
Morris water maze test. The mean distance from the
platform (mean search error) during training trials was
determined. Mice that failed to escape from the water
within 60 s were guided to the platform and allowed to
remain there for 30 s. During the training (acquisition)
trials, search errors that are described in detail elsewhere
[27] were used to assess the performance accuracy of
spatial learning in the water maze. During each trial, the
distance of the mice from the escape platform was sam-
pled 10 times per second, and these values were aver-
aged in 1-s bins. The cumulative search error was then
calculated as the summed 1-s averages of the proximity
measures corrected for the particular start location in
each trial. On day 12 and 14, 30 min after the last trial,
the platform was removed from the tank, and the mice
underwent a spatial probe trial in which they were given
60 s to search for the removed platform. The time spent
in the target quadrant was measured. A camera located
above the center of the maze relayed images to a video-
cassette recorder. Data from the water maze trials were
analyzed using the human visual system Image Software
(HVS Image, Hampton, UK).
Acetylcholinesterase activity assay
The Amplex Red Acetylcholine/Acetylcholinesterase
assay kit was used to determine acetylcholinesterase ac-
tivity. Working solution of 400 μM Amplex Red reagent
containing 2 U/ml horseradish peroxidase and 0.2 U/ml
choline oxidase was prepared from stock solution, and
100 μM ACh was added to measure AChE activity. The
reaction began when 100 μl of the working solution was
added to microplate wells containing hippocampus ly-
sates. Fluorescence emitted by individual samples was
detected using a VersaMax ELISA microplate reader
(Molecular Devices, Sunnyvale, CA, USA) at an excita-
tion wavelength of 560 nm and emission wavelength of
590 nm. Background fluorescence was eliminated by
subtracting values derived from the negative control.
Western blot analysis
The proteins (100 μg) from hippocampus lysates were sepa-
rated by 10 % sodium dodecyl sulfate polyacrylamide gel
electrophoresis and electrophoretically transferred to a
polyvinylidene fluoride membrane (Millipore, Billerica,
MA, USA). The membrane was blocked in 5 % fat-free dry
milk and then incubated with primary antibodies against p-
p65 and β-actin. After incubation with horseradish-
peroxidase-conjugated secondary antibodies, protein bands
were detected using an enhanced chemiluminescence
detection kit (GE Healthcare, St. Giles, UK).
Statistical analysis
Statistical analyses were performed using SPSS 19.0 for
Windows (SPSS Inc., Chicago, IL, USA). Results were
expressed as mean ± standard error of the mean (SEM).
Morris water maze data were analyzed by one-way re-
peated analysis of variance (ANOVA), followed by Fisher’s
least significant difference (LSD) test. The probe test and
remaining data were analyzed by one-way ANOVA,
followed by Tukey’s post-hoc test.
Results
Rg3GE inhibited scopolamine-induced impairment of
spatial memory
To determine the effects of Rg3GE in cognitive function,
the Morris water maze test was performed. We first investi-
gated whether Rg3GE, RGE, or scopolamine alters the body
weight or swimming speed of each mouse. Mouse body
weights were measured on days 1–14 during the treatments
with Rg3GE, RGE, and scopolamine, and no significant
differences were found between the different groups (non-
induction + vehicle, scopolamine + vehicle, scopolamine +
Rg3GE, scopolamine + RGE; F(4,45) = 0.662; p = 0.621;
Fig. 3a). The swimming speed of each mouse was also mea-
sured for days 9–14 during the training trials of the Morris
water maze test, and these values were also not found to be
significantly different between groups (non-induction + ve-
hicle, scopolamine + vehicle, scopolamine + Rg3GE, scopol-
amine + RGE; F(4,45) = 0.613; p = 0.656; Fig. 3b). These
data suggest that Rg3GE, RGE, and scopolamine do not
affect the body weight or swimming speed of the mice.
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Analysis of mean search error (i.e., mean distance from
the escape platform during the search) revealed signifi-
cant differences between the groups (non-induction +
vehicle, scopolamine + vehicle, scopolamine + Rg3GE,
scopolamine + RGE; F(5,54) = 8.948; p < 0.001), as well as
with training (F(5270) = 61.579, p < 0.001). However, a
significant interaction between treatment and training
session was not detected (F(25,270) = 0.724; p = n.s). As
shown in Fig. 4, the control mice became proficient at
locating the submerged platform during the training
sessions; however, scopolamine + vehicle-treated mice
showed little improvement over the course of training.
Post-hoc analysis confirmed that the mean search error
of the control mice was significantly lower than that of
scopolamine + vehicle-treated mice (p < 0.001). However,
scopolamine-treated mice that also received Rg3GE
(100 mg/kg, but not 50 mg/kg) or RGE (100 mg/kg) per-
formed significantly better than those that received
scopolamine alone (Rg3GE 50 mg/kg: p =0.137; Rg3GE
100 mg/kg: p = 0.018; RGE 100 mg/kg: p = 0.022; Fig. 4a).
The effect of Rg3GE at 100 mg/kg on the scopolamine-
induced learning deficit was similar compared to RGE at
100 mg/kg (p = 0.935). These observations suggest that
Fig. 3 Effects of Rg3GE or RGE with scopolamine on the (a) weight
and (b) speed of mice. Mouse body weights were measured on
days 1–14, during treatment with Rg3GE (50 or 100 mg/kg, p.o.),
RGE (100 mg/kg, p.o.), and scopolamine (1 mg/kg, i.p.). The
swimming speed of each mouse was also measured for days 9–14
during the training trials of the Morris water maze test. Statistical
analysis was performed by one-way repeated ANOVA followed by
Fisher’s LSD test. Data are expressed as mean ± SEM (n = 10)
Fig. 4 Effect of Rg3GE on scopolamine-induced impairment of spatial
memory during the training period for the Morris water maze test. a
Rg3GE (50 or 100 mg/kg, p.o.) or RGE (100 mg/kg, p.o.) was administered
prior to the training trials for the Morris water maze test (days 1–8) and
continued on days 9–14, during which the Morris water maze test was
carried out. Impairment of spatial memory was induced by scopolamine
(SCO, 1 mg/kg, administered by i.p. injection on days 9–14). During the
training period (days 9–14), we evaluated the mean search error. b On
days 12 and 14, probe trials were conducted to measure the retention
of spatial memory. In the probe trial on day 14, vehicle control mice
spent significantly more time in the target quadrant than did
scopolamine-treated mice (#). However, Rg3GE or RGE treatments did
not improve performance of the scopolamine-treated mice. Statistical
analysis was performed by one-way repeated ANOVA, followed by
Fisher’s LSD test. Data are expressed as mean ± SEM (n = 10)
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Rg3GE inhibited the scopolamine-induced impairment
of spatial memory acquisition.
On day 12, the mice underwent the spatial probe test
to determine whether they remembered the platform
location. One-way ANOVA revealed no significant dif-
ferences between treatment groups. On day 14, the mice
underwent another spatial probe test. One-way ANOVA
revealed significant differences between the treatment
groups (F(5, 270) = 2.664; p < 0.05). Subsequent post-hoc
analyses revealed significant differences between the
vehicle-treated and scopolamine-treated mice (p < 0.05;
Fig. 4b). However, Rg3GE or RGE treatment did not
result in any improvement in spatial memory retention.
Rg3GE suppressed scopolamine-induced acetylcholin-
esterase activity
We examined the effect of Rg3GE on acetylcholin-
esterase activity in the hippocampus (Fig. 5). Scopol-
amine + vehicle-treated mice showed significantly
increased acetylcholinesterase activity compared with
non-induction + vehicle-treated control mice. Rg3GE
(50 and 100 mg/kg) administration significantly
inhibited acetylcholinesterase activity, compared with
that of the scopolamine + vehicle-treated group. Inter-
estingly, RGE (50 mg/kg) administration did not have
an effect on acetylcholinesterase activity in the
hippocampus.
Rg3GE suppressed scopolamine-induced NF-κB activation
To determine the effect of Rg3GE on inflammatory signal-
ing molecules in the hippocampus, we evaluated the
phosphorylation of p65 by Western blot analysis (Fig. 6).
We observed phosphorylation of p65 in the hippocampus
of the non-induction + vehicle group. Treatment with
scopolamine + vehicle significantly increased the levels of p-
p65 in the hippocampus compared with non-induction +
vehicle treatment. However, Rg3GE (50 and 100 mg/kg)
administration suppressed the scopolamine-induced phos-
phorylation of p65, and showed even greater suppression of
p65 phosphorylation compared to the non-induction +
vehicle group. RGE (100 mg/kg) administration also inhib-
ited the scopolamine-induced phosphorylation of p65 and
showed even greater suppression of p65 phosphorylation
compared to the non-induction + vehicle group. This obser-
vation suggests that Rg3GE has strong inhibitory activity
on NF-κB activation and suppresses scopolamine-induced
NF-κB activation.
Discussion
Since ginsenoside Rg3 is not naturally present in Panax
ginseng [13] and only occurs in red ginseng by way of a
thermal process [15], we developed the method to increase
the level of Rg3 without thermal processing of ginseng
roots. The prepared Rg3-enriched ginseng extract (Rg3GE)
contains 14.34 ± 0.28 mg/g of Rg3, and we investigated
whether Rg3GE can ameliorate scopolamine-induced im-
pairment of hippocampus-dependent spatial memory. We
found that oral administration of Rg3GE significantly im-
proved the search error of scopolamine-treated mice in the
Morris water maze task, suggesting that Rg3GE is beneficial
in the acquisition of spatial memory. Conversely, we ob-
served that Rg3GE did not improve the retention of spatial
memory retrieval in the probe test.
Chen et al. reported that ginsenoside Rg3 significantly
decreases the levels of amyloid-β40 and amyloid-β42 in cul-
tured cells and transgenic mice (Tg2576) that express high
levels of amyloid-β [28]. Ginsenoside Rg3 protects cultured
cortical neurons from glutamate-induced neurotoxicity [6].
In addition, it exhibits neuroprotective effects after perman-
ent middle cerebral artery occlusion in rats by reducing
lipid peroxides, scavenging free radicals, and improving
energy metabolism [4]. Ginsenoside Rg3 increases
ischemia-induced cell proliferation and survival in the den-
tate gyrus of adult gerbils [4, 29]. These observations po-
tentiate the idea that Rg3 might be a promising compound
that protects the brain and prevents neuronal disorders.
The action of acetylcholine is dependent upon acetyl-
cholinesterase, which hydrolyzes acetylcholine [12, 30].
Inhibition of acetylcholinesterase activity has been the
therapeutic approach used for dementia [31]. To eluci-
date the mechanisms underlying the neuropharmaco-
logical actions of Rg3GE, we assessed its effect on
acetylcholinesterase activity in scopolamine-induced
learning- and memory-deficient mouse brains. Rg3GE
significantly inhibited the scopolamine-induced increase
Fig. 5 Effect of Rg3GE on scopolamine-induced acetylcholinesterase
activation. Mice were decapitated immediately following the Morris
water maze test, and the hippocampi were dissected to assay
acetylcholinesterase activity. Statistical analysis was performed by
one-way ANOVA followed by Turkey’s post-hoc test. Data are
expressed as mean ± SEM (n = 4). Letters (a–c) within a graph are
significantly different from each other at p < 0.05
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in acetylcholinesterase activity in the hippocampus. This
suggests that Rg3GE may have an ameliorating effect on
cholinergic dysfunction-induced memory impairment by
enhancing cholinergic transmission. The beneficial effect
of Rg3GE on the acquisition of spatial memory in
scopolamine-treated mice is likely due to the prevention
of scopolamine-induced dysregulation of acetylcholin-
esterase activity and acetylcholine level.
It has been reported that muscarinic acetylcholine
receptors in the central nervous system inhibit systemic
inflammation and the activation of muscarinic choliner-
gic transmission in the central nervous system lowers
serum tumor necrosis factor (TNF) levels [32]. Since
scopolamine is a nonselective muscarinic receptor antag-
onist, blockage of the muscarinic receptor by scopolam-
ine might promote inflammation and TNF. Previous
studies have confirmed that scopolamine not only im-
pairs the cholinergic system, but also induces the expres-
sion of pro-inflammatory mediators and neurotoxic
cytokines, such as cyclooxygenase-1 (COX-1), COX-2,
TNF-α, and interleukin-1β (IL-1β) [23, 33–38]. It was
also found that scopolamine modulates the stimulation
of NF-κB pathways (i.e., the phosphorylation of IκBα
and p65) [23, 33, 35]. Inflammatory reactions are related
to the pathogenesis of neurodegeneration and cognitive
impairment [39]. Chronic treatment with non-steroidal
anti-inflammatory drugs (NSAIDs) reversed the cogni-
tive deficits in scopolamine-treated mice [34]. Thus,
scopolamine might cause learning and memory deficits
through cholinergic neuronal injury complicated by NF-
κB-mediated inflammation. Rg3GE might ameliorate the
scopolamine-induced impairment of spatial memory by
protecting the cholinergic system via inhibition of NF-
κB signaling.
Conclusions
We have developed a method to increase the level of Rg3
in ginseng roots without the need for a thermal process.
The neuropharmacological effects of Rg3GE were tested.
Rg3GE exhibited potent memory-stabilizing effects, as
assessed by the Morris water maze test, and inhibited
scopolamine-induced acetylcholinesterase activity in the
hippocampus. Rg3GE also decreased the activation of NF-
κB. The effects of Rg3GE were better than or similar to
Fig. 6 Effect of Rg3GE on scopolamine-induced NF-κB activation. a Levels of phosphorylated p65 were determined by Western blot analysis. β-actin
was used as the loading control. b Quantitation of protein levels was achieved through densitometry analysis. Statistical analysis was performed by
one-way ANOVA followed by Tukey’s post-hoc test. Data are expressed as mean ± SEM (n = 3). Letters (a–c) within a graph are significantly different
from each other at p < 0.05
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those of RGE. Our findings suggest that Rg3GE may
improve cognitive deficits via the inhibition of acetyl-
cholinesterase activity and inflammation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JK and JS contributed equally to this work; JS, SL, and WC have conducted
the experiments; EH and JHL provided Rg3GE; JK and JSH supervised the
research, and wrote and corrected the manuscript with JS; KWL and HJL
supervised the research with JK and JS. All the authors read and approved
the final manuscript.
Acknowledgements
This work was funded by the Ministry of Agriculture, Food and Rural Affairs
(Bio-industry Technology Development Program [514004]), the Ministry for
Food, Agriculture, Forestry, and Fisheries, Republic of Korea (Industrialization
Support Program for Biotechnology of Agriculture and Forestry [810002–03])
and the Ministry of Knowledge Economy (National Platform Technology
Project [10033818]). This research was also supported by the Basic Science
Research Program through the National Research Foundation of Korea (NRF)
funded by the Ministry of Science, ICT, and Future Planning
(2015R1A1A3A04000963).
Author details
1WCU Biomodulation Major, Department of Agricultural Biotechnology, Seoul
National University, Seoul 151-742, Republic of Korea. 2Center for Food and
Bioconvergence, Seoul National University, Seoul 151-921, Republic of Korea.
3Research Institute for Veterinary Science, College of Veterinary Medicine,
Seoul National University, Seoul 151-742, Republic of Korea. 4Department of
Biological Sciences, Konkuk University, Seoul 143-701, Republic of Korea.
5Foods R&D, CJ Cheiljedang Corp., Seoul 152-051, Republic of Korea.
6Department of Food Science and Biotechnology, CHA University, Pocheon,
Gyeonggi-do 487-010, Republic of Korea. 7Advanced Institutes of
Convergence Technology, Seoul National University, Suwon 443-270,
Republic of Korea. 8Research Institute of Bio Food Industry, Institute of Green
Bio Science and Technology, Seoul National University, Pyeongchang
232-916, Republic of Korea.
Received: 11 May 2015 Accepted: 12 February 2016
References
1. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents
and multiple actions. Biochem Pharmacol. 1999;58(11):1685–93.
2. Park HJ, Kim DH, Park SJ, Kim JM, Ryu JH. Ginseng in traditional herbal
prescriptions. J Ginseng Res. 2012;36(3):225–41.
3. Liu CX, Xiao PG. Recent advances on ginseng research in China.
J Ethnopharmacol. 1992;36(1):27–38.
4. Tian J, Fu F, Geng M, Jiang Y, Yang J, Jiang W, et al. Neuroprotective effect
of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats. Neurosci Lett.
2005;374(2):92–7.
5. Yang L, Hao J, Zhang J, Xia W, Dong X, Hu X, et al. Ginsenoside Rg3
promotes beta-amyloid peptide degradation by enhancing gene expression
of neprilysin. J Pharm Pharmacol. 2009;61(3):375–80.
6. Kim YC, Kim SR, Markelonis GJ, Oh TH. Ginsenosides Rb1 and Rg3 protect
cultured rat cortical cells from glutamate-induced neurodegeneration.
J Neurosci Res. 1998;53(4):426–32.
7. Brandon EP, Mellott T, Pizzo DP, Coufal N, D’Amour KA, Gobeske K, et al.
Choline transporter 1 maintains cholinergic function in choline
acetyltransferase haploinsufficiency. J Neurosci Off J Soc Neurosci. 2004;
24(24):5459–66.
8. Jeong EJ, Lee KY, Kim SH, Sung SH, Kim YC. Cognitive-enhancing and
antioxidant activities of iridoid glycosides from Scrophularia buergeriana in
scopolamine-treated mice. Eur J Pharmacol. 2008;588(1):78–84.
9. Jones RW, Wesnes KA, Kirby J. Effects of NMDA modulation in scopolamine
dementia. Ann N Y Acad Sci. 1991;640:241–4.
10. Abe E. Reversal effect of DM-9384 on scopolamine-induced acetylcholine
depletion in certain regions of the mouse brain. Psychopharmacology.
1991;105(3):310–6.
11. Lee S, Kim J, Seo SG, Choi BR, Han JS, Lee KW, et al. Sulforaphane alleviates
scopolamine-induced memory impairment in mice. Pharmacol Res.
2014;85:23–32.
12. Bartus RT, Dean 3rd RL, Beer B, Lippa AS. The cholinergic hypothesis of
geriatric memory dysfunction. Science. 1982;217(4558):408–14.
13. Popovich DG, Kitts DD. Generation of ginsenosides Rg3 and Rh2 from North
American ginseng. Phytochemistry. 2004;65(3):337–44.
14. Sun S, Wang CZ, Tong R, Li XL, Fishbein A, Wang Q, et al. Effects of
steaming the root of Panax notoginseng on chemical composition and
anticancer activities. Food Chem. 2010;118(2):307–14.
15. Kim OT, Yoo NH, Kim GS, Kim YC, Bang KH, Hyun DY, et al. Stimulation of
Rg3 ginsenoside biosynthesis in ginseng hairy roots elicited by methyl
jasmonate. Plant Cell Tiss Org. 2013;112(1):87–93.
16. Broks P, Preston GC, Traub M, Poppleton P, Ward C, Stahl SM. Modelling
dementia: effects of scopolamine on memory and attention.
Neuropsychologia. 1988;26(5):685–700.
17. Sunderland T, Tariot PN, Weingartner H, Murphy DL, Newhouse PA,
Mueller EA, et al. Pharmacologic modelling of Alzheimer’s disease. Prog
Neuro-Psychopharmacol Biol Psychiatry. 1986;10(3–5):599–610.
18. Ghumatkar PJ, Patil SP, Jain PD, Tambe RM, Sathaye S. Nootropic,
neuroprotective and neurotrophic effects of phloretin in scopolamine
induced amnesia in mice. Pharmacol Biochem Behav. 2015;135:182–91.
19. Hasanein P, Mahtaj AK. Ameliorative effect of rosmarinic acid on scopolamine-
induced memory impairment in rats. Neurosci Lett. 2015;585:23–7.
20. Hashimoto T, Hatayama Y, Nakamichi K, Yoshida N. Procognitive effect of
AC-3933 in aged mice, and synergistic effect of combination with donepezil
in scopolamine-treated mice. Eur J Pharmacol. 2014;745:123–8.
21. Hosseini M, Mohammadpour T, Karami R, Rajaei Z, Reza Sadeghnia H,
Soukhtanloo M. Effects of the hydro-alcoholic extract of Nigella sativa on
scopolamine-induced spatial memory impairment in rats and its possible
mechanism. Chin J Integr Med. 2015;21(6):438–44.
22. Jamialahmadi K, Sadeghnia HR, Mohammadi G, Kazemabad AM, Hosseini M.
Glucosamine alleviates scopolamine induced spatial learning and memory
deficits in rats. Pathophysiol. 2013;20(4):263–7.
23. Jang YJ, Kim J, Shim J, Kim CY, Jang JH, Lee KW, et al. Decaffeinated coffee
prevents scopolamine-induced memory impairment in rats. Behav Brain Res.
2013;245:113–9.
24. Lee B, Park J, Kwon S, Park MW, Oh SM, Yeom MJ, et al. Effect of wild
ginseng on scopolamine-induced acetylcholine depletion in the rat
hippocampus. J Pharm Pharmacol. 2010;62(2):263–71.
25. Ohba T, Yoshino Y, Ishisaka M, Abe N, Tsuruma K, Shimazawa M, et al.
Japanese Huperzia serrata extract and the constituent, huperzine A,
ameliorate the scopolamine-induced cognitive impairment in mice. Biosci
Biotechnol Biochem. 2015;79:1838.
26. Xian YF, Ip SP, Mao QQ, Su ZR, Chen JN, Lai XP, et al. Honokiol improves
learning and memory impairments induced by scopolamine in mice. Eur J
Pharmacol. 2015;760:88–95.
27. Gallagher M, Burwell R, Burchinal M. Severity of spatial learning impairment
in aging: development of a learning index for performance in the Morris
water maze. Behav Neurosci. 1993;107(4):618–26.
28. Chen F, Eckman EA, Eckman CB. Reductions in levels of the Alzheimer’s
amyloid beta peptide after oral administration of ginsenosides. FASEB J.
2006;20(8):1269–71.
29. Shen L, Zhang J. Ginsenoside Rg1 increases ischemia-induced cell
proliferation and survival in the dentate gyrus of adult gerbils. Neurosci Lett.
2003;344(1):1–4.
30. Eichenbaum H. How does the brain organize memories? Science.
1997;277(5324):330–2.
31. Giacobini E. Cholinesterase inhibitors: new roles and therapeutic
alternatives. Pharmacol Res. 2004;50(4):433–40.
32. Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, Czura CJ,
et al. Central muscarinic cholinergic regulation of the systemic inflammatory
response during endotoxemia. Proc Natl Acad Sci U S A. 2006;103(13):5219–23.
33. Lee B, Jung K, Kim DH. Timosaponin AIII, a saponin isolated from
Anemarrhena asphodeloides, ameliorates learning and memory deficits in
mice. Pharmacol Biochem Behav. 2009;93(2):121–7.
34. Jain NK, Patil CS, Kulkarni SK, Singh A. Modulatory role of cyclooxygenase
inhibitors in aging- and scopolamine or lipopolysaccharide-induced
cognitive dysfunction in mice. Behav Brain Res. 2002;133(2):369–76.
35. Jung K, Lee B, Han SJ, Ryu JH, Kim DH. Mangiferin ameliorates scopolamine-
induced learning deficits in mice. Biol Pharm Bull. 2009;32(2):242–6.
Kim et al. BMC Complementary and Alternative Medicine  (2016) 16:66 Page 8 of 9
36. Ahmad A, Ramasamy K, Jaafar SM, Majeed AB, Mani V. Total isoflavones
from soybean and tempeh reversed scopolamine-induced amnesia,
improved cholinergic activities and reduced neuroinflammation in brain.
Food Chem Toxicol. 2014;65:120–8.
37. Lee B, Sur B, Shim I, Lee H, Hahm DH. Phellodendron amurense and Its
Major Alkaloid Compound, Berberine Ameliorates Scopolamine-Induced
Neuronal Impairment and Memory Dysfunction in Rats. Korean J Physiol
Pharmacol. 2012;16(2):79–89.
38. Jawaid T, Shakya AK, Siddiqui HH, Kamal M. Evaluation of Cucurbita maxima
extract against scopolamine-induced amnesia in rats: implication of tumour
necrosis factor alpha. Z Naturforsch C. 2014;69(9–10):407–17.
39. Rothwell N, Allan S, Toulmond S. The role of interleukin 1 in acute
neurodegeneration and stroke: pathophysiological and therapeutic
implications. J Clin Invest. 1997;100(11):2648–52.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kim et al. BMC Complementary and Alternative Medicine  (2016) 16:66 Page 9 of 9
